Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.9K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative interactome mapping of skeletal muscle insulin resistance.

Molecular systems biology·2026
Same author

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.

Cell metabolism·2026
Same author

Embryonic stem cell factors DPPA2/4 amplify active H3K4me3-H2AK119ub chromatin domains in non-small cell lung cancer.

Genes & development·2026
Same author

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.

Cell metabolism·2026
Same author

Intrinsic muscle stem cell dysfunction underlies functional deficits in models of type 1 diabetes.

NPJ Regenerative medicine·2026
Same author

Phosphoproteomics of aged insulin-resistant bone identifies P70S6K phosphorylation of AFF4 as a gene-specific transcriptional regulator.

Nature communications·2025
Same journal

MT-MRI for detection of renal interstitial fibrosis in renovascular disease.

Scientific reports·2026
Same journal

Detection of underground objects from GPR data using a lightweight YOLO-based approach.

Scientific reports·2026
Same journal

Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumab.

Scientific reports·2026
Same journal

Water balance components in a dry-seeded rice-wheat system: Untangling the effects of tillage and mulching practices.

Scientific reports·2026
Same journal

Topological approaches to quantum tensor train compression via ZX-calculus and SVD.

Scientific reports·2026
Same journal

determinants of flood impacts and adaptive capacity among market vendors in Walukuba-Masese, Jinja city, Uganda.

Scientific reports·2026
See all related articles

Related Experiment Video

Updated: Sep 7, 2025

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.3K

SILAC kinase screen identifies potential MASTL substrates.

Kamila A Marzec1, Samuel Rogers2, Rachael McCloy3

  • 1ANZAC Research Institute, Concord Hospital, Concord, NSW, 2139, Australia.

Scientific Reports
|June 22, 2022
PubMed
Summary
This summary is machine-generated.

Microtubule-associated serine/threonine kinase-like (MASTL) may phosphorylate new substrates beyond Arpp-19/ENSA. This kinase

More Related Videos

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.3K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.3K

Related Experiment Videos

Last Updated: Sep 7, 2025

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.3K
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.3K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.3K

Area of Science:

  • Cell Biology
  • Biochemistry
  • Oncology

Background:

  • Microtubule-associated serine/threonine kinase-like (MASTL) is a key regulator of mitosis.
  • MASTL is implicated as an oncogene in various cancers.
  • Currently, Arpp-19/ENSA are the sole identified substrates of MASTL.

Purpose of the Study:

  • To identify novel substrates of MASTL.
  • To determine the optimal consensus motif for MASTL activity.
  • To understand MASTL's expanding biological roles in cancer.

Main Methods:

  • Utilized a whole cell lysate in vitro kinase screen.
  • Employed stable isotope labeling with amino acids in cell culture (SILAC) for substrate identification.
  • Validated potential substrates using subsequent in vitro kinase assays.

Main Results:

  • Identified 59 phospho-sites on 67 proteins regulated by active MASTL.
  • The kinase screen, validated with AKT1/2, identified known and novel substrates.
  • hnRNPM, YB1, and TUBA1C were suggested as potential MASTL substrates in vitro.

Conclusions:

  • MASTL likely phosphorylates additional substrates beyond Arpp-19/ENSA.
  • These findings offer insights into MASTL's role in cancer progression and therapy resistance.
  • Further research into MASTL substrates is crucial for developing targeted cancer therapies.